TOTALLY IMPLANTABLE CENTRAL VENOUS ACCESS DEVICES IN CHILDREN WITH HEMATO-ONCOLOGIC MALIGNANCIES: Evaluation of Complications and Comparison of Incidence of Febrile Episodes with Similar Patients Without Central Venous Access Devices
Authors:
- 1 January 2006
- journal article
- research article
- Published by Taylor & Francis in Pediatric Hematology and Oncology
- Vol. 23 (6) , 459-470
Abstract
The incidence of mechanical and infectious complications of totally implantable central venous access devices (TIDs) must be related to underlying disease, intensity of the chemotherapy, and frequency of manipulations. Records of the patients hospitalized from January 2002 to May 2005 were evaluated. Patients with TIDs were matched with patients without TIDs having the same malignancy and the same anti-neoplastic chemotherapy. Catheter-related complications were documented and corresponding phases of the chemotherapy in matched pairs were compared with regard to infections. TIDs were inserted in 31 patients with a median age of 4.3 years (22 acute leukemia, 1 NHL, and 8 solid tumors). Total number of catheter days was 5268, with a median catheter life of 174 days (range 9–493 days). Nine catheters (29%) were removed due to mechanical and infectious complications. There was 13 catheter-related infections with a rate of 2.46/1000 catheter days. Total number of mechanical complications was 5 and overall rate of complications was 3.41/1000 catheter days. The rate of febrile episodes was 54 and 41 in the TID and no TID group, respectively (p:. 11). Duration of neutropenia was 9.6 and 7.4 days and duration of fever per febrile attack was 5.6 and 4.4 days in the TID and no TID group, respectively (p:. 047 and. 56). Although most of the patients in this study had hematological malignancy and required frequent manipulation, the results were similar to those in developed countries. TIDs are essential for management of chemotherapy in pediatric malignancies with acceptable complications.Keywords
This publication has 16 references indexed in Scilit:
- Central Vascular Access Devices in Oncology and Hematology Considered From a Different Point of ViewJournal of Infusion Nursing, 2005
- Port-A-Cath infections in children with cancerEuropean Journal of Cancer, 2004
- Cutaneous bacterial colonization, modalities of chemotherapeutic infusion, and catheter-related bloodstream infection in totally implanted venous access devicesSupportive Care in Cancer, 2004
- Totally implantable subcutaneous port system versus central venous catheter placed before induction chemotherapy in patients with acute leukaemia?a randomized studySupportive Care in Cancer, 2004
- Factors influencing central line infections in children with acute lymphoblastic leukemia: Results of a single institutional studyPediatric Blood & Cancer, 2003
- The Promise of Novel Technology for the Prevention of Intravascular Device–Related Bloodstream Infection. II. Long‐Term DevicesClinical Infectious Diseases, 2002
- Longterm central venous access in gynecologic cancer patients11No competing interests declared.Journal of the American College of Surgeons, 2000
- Central Venous Catheter Use and the Risk of Infection in Children With Acute Lymphoblastic LeukemiaJournal of Pediatric Hematology/Oncology, 1999
- Totally implantable vascular access devices in 131 pediatric oncology patientsPediatric Surgery International, 1996
- Complications of Indwelling Venous Access Lines in the Pediatric Hematology PatientJournal of Pediatric Hematology/Oncology, 1991